Companies in the Financial sector have received a lot of coverage today as analysts weigh in on Healthequity (HQY – Research Report) and Meridian Bank (MRBK – Research Report).
Healthequity (HQY)
In a report released today, Sean Dodge from RBC Capital reiterated a Buy rating on Healthequity, with a price target of $75.00. The company’s shares closed last Wednesday at $59.16.
According to TipRanks.com, Dodge is a 1-star analyst with an average return of
Currently, the analyst consensus on Healthequity is a Strong Buy with an average price target of $80.11, which is a 34.1% upside from current levels. In a report issued on March 7, BTIG also maintained a Buy rating on the stock with a $85.00 price target.
See today’s best-performing stocks on TipRanks >>
Meridian Bank (MRBK)
KBW analyst Michael Perito maintained a Hold rating on Meridian Bank today and set a price target of $17.00. The company’s shares closed last Wednesday at $13.56.
Perito has an average return of
According to TipRanks.com, Perito is ranked #428 out of 8338 analysts.
The word on The Street in general, suggests a Hold analyst consensus rating for Meridian Bank.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on HQY:
- HealthEquity Reports Fiscal Year and Fourth Quarter Ended January 31, 2023 Financial Results
- HealthEquity Sets Date to Announce Fourth Quarter and Fiscal Year End Results
- HealthEquity Reports Record HSA Sales, Asset Growth
- HealthEquity Continues to Lead in Gender Equality and as a Top Workplace
- HealthEquity price target lowered to $89 from $101 at Wells Fargo
